April 2015

Incorporated in 1990, Strides Arcolab is a first generation, pharmaceutical company headquartered in Bangalore, India. With business interests in differentiated Pharma generics, branded generics, and bio-Pharma. Strides Arcolab is a valued player in the global healthcare industry.
With world-class manufacturing operations, the company has 8 manufacturing facilities presence in more than 75 countries in developed and emerging markets and an innovative R&D hub in Bangalore. The core competence is in the development and manufacture of niche and technically complex pharmaceutical products. Strides are also among the world's largest soft gelatin capsule manufacturers and have done acquisitions in South East Asia and Australian Regions. In December 2013, Agila business (injectable product line) was sold to Mylan in order to grow organically.

Post: VP /AVP-Quality Control

Banaras Hindu University ranks among the first few in the country in the field of academic and research output. This university has two campuses, 3 institutes, 16 faculties, 140 departments, 4 advanced centers and 4 interdisciplinary schools. The University is making its mark at the national and international levels in a number of frontier areas of Science, Social Science, Technology, Medicine and Agriculture etc.

Post: Research Associate, Senior Research Fellow, Junior Research Fellow

The CHC Group in India is a leading Distributor since 2005. We are service provider and implementer of leading-edge technology enabled solutions operating in the core business segments of Healthcare and Health Care Outsourcing. Health Care, a part of CHC Group is a leading international health care KPO and BPO service provider with 10 years of rich experience in this domain with a strong professional work force of 200+ with a projection to cross 500+ by end of 2015.

Post: Clinical Tutor/Educator

{ DOWNLOAD AS PDF }

ABOUT AUTHROS:
Bikash Debnath*, Md. JashimUddin, Debasish Maiti
State Biotech Hub, Department of Human Physiology,
Tripura University, Suryamaninagar.
*bikashrips2014@gmail.com

ABSTRACT:
Central nervous system (CNS) drug development will be biology driven. Due to absence of functional platform for CNS drug targeting since, the large molecules pharmaceuticals cannot be delivered to brain. About 1.5 billion people worldwide are suffering from various type of central nervous system (CNS) disorders. Overcome to this problem modern pharmaceutical technology manufacturing the nonaparticles. Properly use of nonamedicines (nanoparticles) is one of the ways to control the CNS disorder in all over world. Nanoparticles are particles between 1 to 100 nm in size. Using nanotechnology it is possible to deliver the drug to the specific site of the tissue across the Blood -Brain Barrier (BBB).Various types of nanoparticle are available for treatment of CNS disorders. These are lipid based nanoparticles, solid lipid nanoparticles, polymer-based nanoparticles etc.

The National Institute of Pharmaceutical Education and Research (NIPER) has been created as a centre of excellence for higher education, research and development in pharmaceutical sciences. NIPER, Rae Bareli at ITI campus, Rae Bareli under the mentor Institute of CSIR - Central Drug Research Institute, Lucknow invites eligible candidates for following positions on purely temporary basis on contract initially for a period of 1 year which can be extended further. The selected candidates shall have no claim for regularization against any regular post either in NIPER or CDRI.

Post: Lecturer